Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Metabolomics : Official Journal of the Metabolomic Society
|
September 20, 2016
Metabolomics enables precision medicine: "A White Paper, Community Perspective"
Richard D Beger, Warwick Dunn, Michael A Schmidt, et al.
Nature Communications
|
July 12, 2019
Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
Mark R Viant, Timothy M D Ebbels, Richard D Beger, et al.
Frontiers in Pharmacology
|
May 1, 2024
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
Amy L Inselman, Elysia A Masters, Jalina N Moore, et al.
The Journal of Allergy and Clinical Immunology
|
March 28, 2025
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
Ronald L Rabin, Matthew C Altman, S Hasan Arshad, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)
Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
October 12, 2020
Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners
Anne M Evans, Claire O'Donovan, Mary Playdon, et al.
Archives of Toxicology
|
October 26, 2017
Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans
Dianke Yu, Leihong Wu, Pritmohinder Gill, et al.
Toxicologic Pathology
|
May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone
Robert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology
|
January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary results
Robert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Analytical Chemistry
|
December 6, 2023
Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples
Corey D Broeckling, Richard D Beger, Leo L Cheng, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Metabolomics : Official Journal of the Metabolomic Society
|
September 20, 2016
Metabolomics enables precision medicine: "A White Paper, Community Perspective"
Richard D Beger, Warwick Dunn, Michael A Schmidt, et al.
Nature Communications
|
July 12, 2019
Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
Mark R Viant, Timothy M D Ebbels, Richard D Beger, et al.
Frontiers in Pharmacology
|
May 1, 2024
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
Amy L Inselman, Elysia A Masters, Jalina N Moore, et al.
The Journal of Allergy and Clinical Immunology
|
March 28, 2025
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
Ronald L Rabin, Matthew C Altman, S Hasan Arshad, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)
Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
October 12, 2020
Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners
Anne M Evans, Claire O'Donovan, Mary Playdon, et al.
Archives of Toxicology
|
October 26, 2017
Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans
Dianke Yu, Leihong Wu, Pritmohinder Gill, et al.
Toxicologic Pathology
|
May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone
Robert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology
|
January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary results
Robert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Analytical Chemistry
|
December 6, 2023
Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples
Corey D Broeckling, Richard D Beger, Leo L Cheng, et al.
Page
of 12